Dual implantable electronic device therapy

Dual-implantable electronic device (IED) therapy is challenging since potential device interaction might occur resulting in inappropriate ICD therapy. A 57-year-old male was referred to our implantable cardioverter defibrillator (ICD) clinic for interrogation of his ICD before, during and after implantation of a device for gastric electrical stimulation (GES). Implantation of the device for GES (Figure) was scheduled for the treatment of the patient's severe chronic intractable nausea secondary to diabetic gastroparesis. We investigated the safety and efficacy of the GES device in this ICD patient up to 3 months after GES device implantation. During follow-up, no interactions of the dual-IED therapy were detected with the applied device programming. The GES device provided symptom relief and the proper functioning of each of the dual IEDs was assured by device interrogation. The full-length version of this report can be viewed at: http://www.escardio.org/communities/EHRA/publications/ep-case-reports/Documents/Dual-implantable-electronic-device-therapy.pdf.